뉴스벤징가
Johnson & Johnson Says Lung Cancer Drug Shows Reduced Side Effects and Longer Patient Survival
· 발표
기사 요약
Johnson & Johnson released positive Phase 2b and Phase 3 trial results for its Rybrevant lung cancer treatment combinations.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…